loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 6c212466 Ff8d Ecfc Ede2 Ef8bdcaaf114 Applno 203491 Form Suspension Drops Ophthalmic Dosage 0 3 - Drug Product Composition: Nepafenac

    Menu

    Nepafenac

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 16,053Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203491 / DOSAGE - SUSPENSION/DROPS;OPHTHALMIC - 0.3%

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    Nepafenac(UNII: 0J9L7J6V8C)
    (Nepafenac - UNII:0J9L7J6V8C)     		Nepafenac3mg in 1

    Inactive Ingredients

    Ingredient Name
    Alcon Laboratories, Inc.
    Benzalkonium Chloride(F5UM2KM3W7)
    Boric Acid(R57ZHV85D4)
    Carbomer Homopolymer Type B (allyl Pentaerythritol Crosslinked)(HHT01ZNK31)
    Carboxymethylcellulose Sodium(K679OBS311)
    Edetate Disodium(7FLD91C86K)
    Guar Gum(E89I1637KE)
    Hydrochloric Acid(QTT17582CB)
    Propylene Glycol(6DC9Q167V3)
    Sodium Chloride(451W47IQ8X)
    Sodium Hydroxide(55X04QC32I)
    Water(059QF0KO0R)